# Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)

> **NCT01349907** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 322 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Asenapine
- **DRUG:** Rescue medication

## Key facts

- **NCT ID:** NCT01349907
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-16
- **Primary completion:** 2014-09-05
- **Final completion:** 2014-09-05
- **Target enrollment:** 322 (ACTUAL)
- **Last updated:** 2024-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01349907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01349907, "Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01349907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*